問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Medical University Hospital (在職)

Division of Obstetrics & Gynecology

更新時間:2023-09-19

張景文
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2025-07-01 - 2029-06-30

Phase II

Active
Clinical trial of PVX4 for the treatment of HPV16-positive cervical intraepithelial neoplasia
  • Condition/Disease

    Human papillomavirus type 16 (HPV) type 16 (HPV type 16) cervical precancerous lesions (HPV type 16, HPV type 16, HPV type 2, HPV type 3, HPV type 3)

  • Test Drug

    PVX4

Participate Sites
9Sites

Recruiting9Sites

2019-01-01 - 2030-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
14Sites

Recruiting1Sites

Terminated13Sites

王鵬惠
Taipei Veterans General Hospital

Division of Obstetrics & Gynecology

2019-12-01 - 2022-12-20

Phase III

A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study, Followed by a Non-Controlled Extension Treatment Period, to Assess the Efficacy and Safety of Fezolinetant in Women in Asia Suffering From Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause
  • Condition/Disease

    Severe Vasomotor Symptoms (Hot Flashes)

  • Test Drug

    Fezolinetant

Participate Sites
11Sites

Not yet recruiting8Sites

Recruiting1Sites

Terminated2Sites